Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Partridge

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Human Hypertension|June 28, 2024
Investigation and management of young-onset hypertension: British and Irish hypertension society position statementSpoorthy Kulkarni, Luca Faconti, Sarah Partridge, et al.
JAMA Oncology|September 13, 2019
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With CancerDavid J Pinato, Sarah Howlett, Diego Ottaviani, et al.
Chemotherapy|April 28, 2024
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour BurdenJames Alexander Korolewicz, Bernhard Scheiner, Claudia A M Fulgenzi, et al.
International Journal of Cancer|April 30, 2024
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UKIfigenia Vasiliadou, Derek Grose, Christina Wilson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Human Hypertension|June 28, 2024
Investigation and management of young-onset hypertension: British and Irish hypertension society position statementSpoorthy Kulkarni, Luca Faconti, Sarah Partridge, et al.
JAMA Oncology|September 13, 2019
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With CancerDavid J Pinato, Sarah Howlett, Diego Ottaviani, et al.
Chemotherapy|April 28, 2024
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour BurdenJames Alexander Korolewicz, Bernhard Scheiner, Claudia A M Fulgenzi, et al.
International Journal of Cancer|April 30, 2024
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UKIfigenia Vasiliadou, Derek Grose, Christina Wilson, et al.
Pageof 2